Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 516318, 14 pages
http://dx.doi.org/10.1155/2015/516318
Research Article

The Use of an IL-1 Receptor Antagonist Peptide to Control Inflammation in the Treatment of Corneal Limbal Epithelial Stem Cell Deficiency

1Biomaterials and Medical Devices Research Group, School of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton BN2 4GJ, UK
2Blond McIndoe Research Foundation, Queen Victoria Hospital, East Grinstead RH19 3DZ, UK
3Brighton Studies in Tissue-Mimicry and Aided Regeneration, School of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton BN2 4GJ, UK

Received 15 September 2014; Revised 2 November 2014; Accepted 3 November 2014

Academic Editor: Achim Langenbucher

Copyright © 2015 E. Fok et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

E. Fok, S. R. Sandeman, A. L. Guildford, and Y. H. Martin, “The Use of an IL-1 Receptor Antagonist Peptide to Control Inflammation in the Treatment of Corneal Limbal Epithelial Stem Cell Deficiency,” BioMed Research International, vol. 2015, Article ID 516318, 14 pages, 2015. https://doi.org/10.1155/2015/516318.